Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,030 | 1,020 | 150 | 190 | 4 |
| Receivables | 1,470 | 2,710 | 0 | 0 | 0 |
| Inventories | 5,960 | 8,060 | 0 | 0 | 0 |
| Other current assets | 10 | 50 | 10 | 0 | 6 |
| TOTAL | $10,470 | $11,840 | $160 | $190 | $10 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 475 | 535 | 5 | 5 | 5 |
| TOTAL | $475 | $535 | $5 | $5 | $5 |
| Total Assets | $11,820 | $13,090 | $170 | $220 | $40 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,720 | 7,900 | 130 | 150 | 130 |
| TOTAL | $6,720 | $7,900 | $130 | $150 | $130 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,900 | 4,640 | 4,380 | 4,130 | 5,840 |
| Other Non-Current Liabilities | 15,200 | 14,900 | 9,610 | 9,310 | 10,610 |
| TOTAL | $20,100 | $19,540 | $13,990 | $13,440 | $16,450 |
| Total Liabilities | $26,830 | $27,450 | $14,130 | $13,600 | $16,590 |
| Shareholders' Equity | |||||
| Common Shares | 1,100 | 1,100 | 1,090 | 1,090 | 1,090 |
| Retained earnings | -49,610 | -48,740 | -48,310 | -47,730 | -43,290 |
| Other shareholders' equity | 230 | 10 | 10 | 10 | 0 |
| TOTAL | $-15,010 | $-14,360 | $-13,950 | $-13,370 | $-16,540 |
| Total Liabilities And Equity | $11,820 | $13,090 | $180 | $230 | $50 |